Kinetic mechanism of human glutathione-dependent formaldehyde dehydrogenase.
- Authors
- Sanghani, P C; Stone, C L; Ray, B D; Pindel, E V; Hurley, T D; Bosron, W F
- Year
- 2000
- Journal
- Biochemistry
- PMID
- 10978156
- DOI
- 10.1021/bi9929711
Formaldehyde, a major industrial chemical, is classified as a carcinogen because of its high reactivity with DNA. It is inactivated by oxidative metabolism to formate in humans by glutathione-dependent formaldehyde dehydrogenase. This NAD(+)-dependent enzyme belongs to the family of zinc-dependent alcohol dehydrogenases with 40 kDa subunits and is also called ADH3 or chi-ADH. The first step in the reaction involves the nonenzymatic formation of the S-(hydroxymethyl)glutathione adduct from formaldehyde and glutathione. When formaldehyde concentrations exceed that of glutathione, nonoxidizable adducts can be formed in vitro. The S-(hydroxymethyl)glutathione adduct will be predominant in vivo, since circulating glutathione concentrations are reported to be 50 times that of formaldehyde in humans. Initial velocity, product inhibition, dead-end inhibition, and equilibrium binding studies indicate that the catalytic mechanism for oxidation of S-(hydroxymethyl)glutathione and 12-hydroxydodecanoic acid (12-HDDA) with NAD(+) is random bi-bi. Formation of an E.NADH.12-HDDA abortive complex was evident from equilibrium binding studies, but no substrate inhibition was seen with 12-HDDA. 12-Oxododecanoic acid (12-ODDA) exhibited substrate inhibition, which is consistent with a preferred pathway for substrate addition in the reductive reaction and formation of an abortive E.NAD(+).12-ODDA complex. The random mechanism is consistent with the published three-dimensional structure of the formaldehyde dehydrogenase.NAD(+) complex, which exhibits a unique semi-open coenzyme-catalytic domain conformation where substrates can bind or dissociate in any order.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genes encoding enzymes involved in ethanol metabolism. | 2012 | 23134050 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Supersulfide catalysis for nitric oxide and aldehyde metabolism. | Kasamatsu S et al. | — | 2023 | → |
| Unique alcohol dehydrogenases involved in algal sugar utilization by marine bacteria. | Brott S et al. | — | 2023 | → |
| Genotoxic aldehydes in the hematopoietic system. | Wang M et al. | — | 2022 | → |
| Genetically encoded formaldehyde sensors inspired by a protein intra-helical crosslinking reaction. | Zhu R et al. | — | 2021 | → |
| Trigenic <i>ADH5</i>/<i>ALDH2</i>/<i>ADGRV1</i> mutations in myelodysplasia with Usher syndrome. | Kinoshita S et al. | — | 2021 | → |
| Altered Plant and Nodule Development and Protein S-Nitrosylation in Lotus japonicus Mutants Deficient in S-Nitrosoglutathione Reductases. | Matamoros MA et al. | — | 2020 | → |
| Amino acid dependent formaldehyde metabolism in mammals. | Pietzke M et al. | — | 2020 | → |
| An emerging perspective on sex differences: Intersecting S-nitrosothiol and aldehyde signaling in the heart. | Casin KM et al. | — | 2020 | → |
| Formate metabolism in health and disease. | Pietzke M et al. | — | 2020 | → |
| The failure of two major formaldehyde catabolism enzymes (ADH5 and ALDH2) leads to partial synthetic lethality in C57BL/6 mice. | Nakamura J et al. | — | 2020 | → |
| Modeling of Human Hepatic and Gastrointestinal Ethanol Metabolism with Kinetic-Mechanism-Based Full-Rate Equations of the Component Alcohol Dehydrogenase Isozymes and Allozymes. | Chi YC et al. | — | 2018 | → |
| The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy. | Barnett SD et al. | — | 2017 | → |
| Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells. | Van Wassenhove LD et al. | — | 2016 | → |
| Antioxidant-Mediated Modulation of Protein Reactivity for 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite. | Anderson DG et al. | — | 2016 | → |
| Crystal structure of AibC, a reductase involved in alternative de novo isovaleryl coenzyme A biosynthesis in Myxococcus xanthus. | Bock T et al. | — | 2016 | → |
| The Effectors and Sensory Sites of Formaldehyde-responsive Regulator FrmR and Metal-sensing Variant. | Osman D et al. | — | 2016 | → |
| Bioinduced Room-Temperature Methanol Reforming. | Heim LE et al. | — | 2015 | → |
| Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen. | Pontel LB et al. | — | 2015 | → |
| Reassessment of MTBE cancer potency considering modes of action for MTBE and its metabolites. | Bogen KT et al. | — | 2015 | → |
| Expression, purification, and characterization of formaldehyde dehydrogenase from Pseudomonas aeruginosa. | Zhang W et al. | — | 2013 | → |
| Structural and functional characterization of a plant S-nitrosoglutathione reductase from Solanum lycopersicum. | Kubienová L et al. | — | 2013 | → |
| Structure of formaldehyde dehydrogenase from Pseudomonas aeruginosa: the binary complex with the cofactor NAD+. | Liao Y et al. | — | 2013 | → |
| The determination of exogenous formaldehyde in blood of rats during and after inhalation exposure. | Kleinnijenhuis AJ et al. | — | 2013 | → |
| Genes encoding enzymes involved in ethanol metabolism. | Hurley TD et al. | — | 2012 | → |
| Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. | Green LS et al. | — | 2012 | → |
| Mammalian alcohol dehydrogenases--a comparative investigation at gene and protein levels. | Höög JO et al. | — | 2011 | → |
| Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase. | Sanghani PC et al. | — | 2009 | → |
| Medium-chain fatty acids and glutathione derivatives as inhibitors of S-nitrosoglutathione reduction mediated by alcohol dehydrogenase 3. | Staab CA et al. | — | 2009 | → |
| Reduction of S-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and leads to GSH-controlled formation of glutathione transferase inhibitors. | Staab CA et al. | — | 2008 | → |
| Glutathione traps formaldehyde by formation of a bicyclo[4.4.1]undecane adduct. | Bateman R et al. | — | 2007 | → |
| Design and characterization of an active site selective caspase-3 transnitrosating agent. | Mitchell DA et al. | — | 2006 | → |
| Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | Gonzàlez-Duarte R et al. | — | 2005 | → |
| Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. | Collins XH et al. | — | 2005 | → |
| Prodrugs of biologically active phosphate esters. | Schultz C | — | 2003 | → |
| Reduction of S-nitrosoglutathione by human alcohol dehydrogenase 3 is an irreversible reaction as analysed by electrospray mass spectrometry. | Hedberg JJ et al. | — | 2003 | → |
| Structure-function relationships in human Class III alcohol dehydrogenase (formaldehyde dehydrogenase). | Sanghani PC et al. | — | 2003 | → |
| The conserved Glu-60 residue in Thermoanaerobacter brockii alcohol dehydrogenase is not essential for catalysis. | Kleifeld O et al. | — | 2003 | → |
| The metabolic role of human ADH3 functioning as ethanol dehydrogenase. | Lee SL et al. | — | 2003 | → |
| The metabolism of nitrosothiols in the Mycobacteria: identification and characterization of S-nitrosomycothiol reductase. | Vogt RN et al. | — | 2003 | → |